Beam Therapeutics Inc

NASDAQ:BEAM   3:59:53 PM EDT
70.40
+1.32 (+1.91%)
Products

Beam Therapeutics Announces FDA Clinical Hold On BEAM-201 IND Application

Published: 08/01/2022 12:02 GMT
Beam Therapeutics Inc (BEAM) - Beam Therapeutics Announces FDA Clinical Hold on Beam-201 Ind Application.
Beam Therapeutics Inc - FDA Indicated They Will Provide an Official Clinical Hold Letter to Beam Within 30 Days.
Beam Therapeutics Inc - Beam Plans to Provide Additional Updates Pending Discussion With FDA.